Announcements
Sidley Represents EDBI in Automera’s US$16M Series A Financing
October 2, 2023
Sidley represented EDBI in its investment in Automera, a company developing an autophagy drug designed to target chimera small molecules (AUTACs), in its US$16M Series A financing round.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
Contacts
Offices
Capabilities
Suggested News & Insights
Sidley Represents Bluevine in Its US$340 Million Acquisition by Valley National BankSeptember 28, 2026Sidley Represents Star51 Capital in Its Investment in UltraSight’s US$24 Million FinancingSeptember 25, 2026Sidley Represents Cymphony in Its US$30 Million Series A FinancingSeptember 18, 2026When the Meeting Minutes and the AI Transcript Don’t Match: Litigation Insights From Delaware ChancerySeptember 17, 2026Sidley Represents Noetive in US$41 Million Series Seed FinancingSeptember 17, 2026Sidley Represents Verily Health in Investment from NVIDIASeptember 11, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory